Clinical trial begins for Chikungunya Vaccine # short stories

New Delhi :  Bharat Biotech said on Monday that the first phase of human clinical trial of the indigenously  developed chikungunya vaccine is underway in India to evaluate its safety, tolerability and immunogenicity. According to a press release issued by the vaccine maker, the ” placebo-controlled” study, involved 60 healthy volunteers, would test escalating doses of the vaccine.


# short stories

For more updates and latest news, please subscribe Newspaper Cuttings.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s